Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
06/07/2011 | US7956049 Melanin concentrating hormone receptor-1 antagonists |
06/07/2011 | CA2470515C Dna minor groove binding compounds |
06/07/2011 | CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
06/03/2011 | WO2011066568A1 Methods for producing textured electrode based energy storage device |
06/03/2011 | WO2011042473A3 Estrogen receptor ligands |
06/03/2011 | WO2010149675A3 Method of synthesizing organic molecules |
06/02/2011 | US20110130538 Photolytic acid-generating polymers and monomers for their construction |
06/02/2011 | US20110130438 Aniline analogs as glycogen synthase activators |
06/02/2011 | US20110129878 Bioreactive agents |
06/01/2011 | EP2327789A1 Novel compound signamycin, method for production thereof, and use thereof |
06/01/2011 | EP2327692A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors |
06/01/2011 | EP2327682A1 Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates |
06/01/2011 | EP2245006B1 Sulfonamides as orexin antagonists |
06/01/2011 | CN102079703A Method for preparing novel nonsteroidal anti-inflammatory drug and anti-inflammatory and analgesic effects thereof |
06/01/2011 | CN101432262B Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
06/01/2011 | CN101392227B Bacillus prodigiosus and prodigiosin produced thereby |
06/01/2011 | CN101070300B Linonene anologs and its preparing method and use |
06/01/2011 | CN101035757B Stabilizers for use in NVP synthesis |
05/31/2011 | US7951972 Human adam-10 inhibitors |
05/31/2011 | US7951960 Black color material and toner |
05/31/2011 | US7951939 Methods and intermediates for the synthesis of porphyrins |
05/31/2011 | US7951752 O-cyclopropyl-carboxanilides and their use as fungicides |
05/31/2011 | US7951211 Quaternary ammonium salt detergents for use in fuels |
05/31/2011 | CA2634299C Process for preparing inhibitors of nucleoside metabolism |
05/31/2011 | CA2603866C Androgen modulators |
05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
05/31/2011 | CA2393232C Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in mri imaging of joints |
05/31/2011 | CA2319080C Multivalent antibacterial agents |
05/31/2011 | CA2172282C Chiral surfactants and methods for their use in chiral separations |
05/26/2011 | WO2011023680A3 Processes for the synthesis and purification of heterobifunctional cross-linkers |
05/26/2011 | WO2010144386A3 Antimicrobial polymers |
05/26/2011 | US20110124882 Method for Preparing N-Substituted Maleimides |
05/26/2011 | US20110124881 Process of forming a pyrrole compound |
05/26/2011 | US20110124705 Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
05/26/2011 | US20110124704 Deuterium-enriched atorvastatin |
05/26/2011 | US20110123976 Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using NMR |
05/26/2011 | US20110123873 Quaternary ammonium salt and composition, and electrochemical device |
05/25/2011 | EP2325179A1 Glycosidase ihhibitors and preparation thereof |
05/25/2011 | EP2325168A1 Polymerizable optically active imide compound and polymerizable composition containing the compound |
05/25/2011 | EP2323977A1 Atorvastatin-aliskiren |
05/25/2011 | EP2323976A1 Aryl alkyl carboxylic acid salts, process for preparation and dosage forms |
05/25/2011 | EP2323972A1 C7-fluoro substituted tetracycline compounds |
05/25/2011 | EP1868994B1 Sulfonylpyrroles as histone deacetylase inhibitors |
05/25/2011 | EP1680395B1 Novel ligand activating rar receptors used in human medicine and cosmetics |
05/25/2011 | CN1926094B Amide derivatives, process for production of the same, and method for application thereof as insecticide |
05/25/2011 | CN1863770B Cyclic amine BASE-1 inhibitors having a heterocyclic substituent |
05/25/2011 | CN102076681A Substituted gamma lactams as therapeutic agents |
05/25/2011 | CN102076655A Insecticidal compounds |
05/25/2011 | CN102076650A Carboxylic acid compound |
05/25/2011 | CN102070505A Atorvastatin calcium compounds and novel preparation method thereof |
05/25/2011 | CN102070504A Method for preparing atorvastatin sodium |
05/25/2011 | CN102070503A Method for preparing pyrrole derivative |
05/25/2011 | CN102070502A Method for preparing (S)-4-hydroxide radical-2-oxo-1-pyrrolidine acetamide |
05/25/2011 | CN102070501A Method for preparing n-methylpyrrolidone from 1,4-butanediol |
05/25/2011 | CN102070451A Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof |
05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
05/24/2011 | US7947845 Process for purifying removal of acrylic acid, methacrylic acid N-vinylpyrrolidone or P-xylene crystals from their suspension in mother liquor |
05/24/2011 | US7947730 Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor |
05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
05/24/2011 | US7947716 N-sulfonylaminocarbonyl containing compounds |
05/24/2011 | US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands |
05/24/2011 | US7947707 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
05/24/2011 | US7947704 2,4,6-phenyl-substituted cyclic ketoenols |
05/24/2011 | US7947513 Sets and compositions pertaining to analyte determination |
05/24/2011 | US7947511 Intensified neutral loss tags and use thereof in mass spectrometry |
05/24/2011 | US7947093 Quaternary ammonium salt detergents for use in fuels |
05/24/2011 | CA2510167C Derivatives of asimadoline with covalently bonded acids |
05/24/2011 | CA2464358C Alkyl ether derivatives or their salts |
05/24/2011 | CA2441235C Aryl and biaryl compounds having mch modulatory activity |
05/19/2011 | WO2011059042A1 Aromatic ring compound |
05/19/2011 | WO2011058975A1 Agent for ameliorating postprandial hyperglycemia, and pyrrolidine iminosugar or salt thereof |
05/19/2011 | WO2011058154A1 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators |
05/19/2011 | WO2011058122A1 Piperidine analogs as glycogen synthase activators |
05/19/2011 | WO2011057477A1 Tetrapeptide analogs, preparation method and use thereof |
05/19/2011 | WO2011057430A1 Chiral n-sulfinyl amino acid amide compounds, preparation method and use thereof |
05/19/2011 | WO2011009047A3 Il-1ra-polymer conjugates |
05/19/2011 | WO2011004972A3 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
05/19/2011 | WO2010149598A3 Heterocyclic antiviral compound |
05/19/2011 | US20110118480 method of synthesizing a substantially monodispersed mixture of oligomers |
05/19/2011 | US20110118470 Nitrogen-containing aromatic derivatives |
05/19/2011 | US20110118329 Uses of ion channel modulating compounds |
05/19/2011 | US20110118328 Novel crystalline forms |
05/19/2011 | US20110118322 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators |
05/19/2011 | US20110118314 Piperidine analogs as glycogen synthase activators |
05/19/2011 | US20110118305 Compounds |
05/19/2011 | US20110118303 Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these |
05/19/2011 | US20110118262 Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors |
05/19/2011 | US20110117057 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
05/19/2011 | CA2789879A1 Dimeric smac mimetics |
05/18/2011 | EP2322506A1 Histamine H3 receptor agents, preparation and therapeutic uses |
05/18/2011 | EP2321274A1 Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors |
05/18/2011 | EP2321267A2 Monoaryl aminotetralines |
05/18/2011 | EP2321011A1 Diaryl compounds and uses thereof |
05/18/2011 | EP2320891A1 Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
05/18/2011 | EP2046779B1 Modulators of chemokine receptor activity, crystalline forms and process |
05/18/2011 | EP1834956B1 Metal complex compound and organic electroluminescent element using the same |
05/18/2011 | EP1467969B1 Dna minor groove binding compounds |
05/18/2011 | EP1192136B1 Oligomers and polymers of cyclic imino carboxylic acids |
05/18/2011 | CN102066322A Compound having NPY Y5 receptor antagonist activity |
05/18/2011 | CN102066321A Pyrrolidine derivatives as NK2 receptor antagonists |